Summary
Cardinal Health Inc. (CAH) reported robust revenue growth for the quarter ending December 31, 2006, with a 13% increase year-over-year, reaching $21.8 billion. This growth was driven by strong performance across all four reportable segments, particularly in the Healthcare Supply Chain Services – Pharmaceutical segment, which constitutes the majority of the company's revenue. Net earnings saw a significant surge of 143% to $739.3 million, largely due to a substantial contribution from discontinued operations, which included a significant tax benefit related to the planned divestiture of the Pharmaceutical Technologies and Services segment. The company also announced a significant strategic move: a $3.3 billion cash sale of its Pharmaceutical Technologies and Services segment to an affiliate of The Blackstone Group, expected to close in the fourth quarter of fiscal year 2007. Proceeds from this sale are earmarked for share repurchases, underscoring a commitment to returning value to shareholders. Despite ongoing legal proceedings and an SEC investigation, the company is managing these challenges, with an agreement-in-principle reached on a potential settlement with the SEC involving a $35 million penalty. Financially, Cardinal Health demonstrated solid operational cash flow generation. The company also announced an increased share repurchase authorization, bringing the total to $4.5 billion, signaling confidence in its future prospects and commitment to shareholder returns. The balance sheet remains strong with total assets of $24.1 billion and total shareholders' equity of $8.9 billion.
Key Highlights
- 1Revenue increased by 13% to $21.8 billion for the quarter ended December 31, 2006, compared to the prior year period, indicating strong top-line growth across segments.
- 2Net earnings surged by 143% to $739.3 million, significantly boosted by earnings from discontinued operations, including a notable tax benefit.
- 3Announced the sale of the Pharmaceutical Technologies and Services segment for approximately $3.3 billion to an affiliate of The Blackstone Group, with an expected closing in Q4 FY2007.
- 4Increased total share repurchase authorization to $4.5 billion, with plans to use proceeds from the PTS segment sale for repurchases.
- 5Operating earnings from continuing operations increased by 12% to $512.1 million, demonstrating continued operational strength.
- 6Maintained a strong balance sheet with total assets of $24.1 billion and total shareholders' equity of $8.9 billion at December 31, 2006.
- 7Received a $35 million penalty as part of an agreement-in-principle to settle an SEC investigation, with $35 million already reserved.